Open for bids Tender Germany ICB TOT Ref. 152582359

Conclusion of a Non-Exclusive Discount Agreement Tender - 152582359

Tender notice from Germany, published on 17 Nov 2026.

Executive Summary

Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Morphine (exclusively in the forms FTA + HKP + SMT) issued by DAK-Gesundheit in Hamburg, Germany. The contract duration is from January 1, 2027, to December 31, 2028, with an option for a one-year extension.

Scope Of Work: The tender involves establishing a framework discount agreement for Morphine, specifically in the forms FTA, HKP, and SMT. This agreement is to be concluded under Section 130a(8) of the German Social Code, allowing health insurance funds and pharmaceutical companies to enter into discount agreements for medicines. DAK-Gesundheit aims to finalize contracts with interested pharmaceutical companies before new agreements come into force on January 1, 2027, and will continue until December 31, 2028, with an optional one-year extension. Interested bidders must submit relevant documents, including a letter of offer, acknowledgment of contractual terms, and completed annexes, by email to DAK-Gesundheit.

Qualification Criterion: Bidders must submit the following documents to DAK-Gesundheit: an offer letter, acknowledgment of the contractual terms including specified discounts, and completed Annexes 1 and 2, which list the medicines related to Morphine. These documents must be sent via email to [email protected] by the 5th of the month preceding the desired contract start date. Late submissions will not be considered for the initial contract period but may be accepted for later entries.

Key facts

Summary
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Morphine (Exclusively in the Dafo. Fta + Hkp + Smt), Atc N02aa01 F. D. Z. 01.01.27-31.12.28, Plus V. Option 1X12m
TOT Ref. No.
152582359
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
17 Nov 2026
Bid deadline
05 Nov 2029
EMD
Refer Document
Tender value
EUR 1.00
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Morphine (Exclusively in the Dafo. Fta + Hkp + Smt), Atc N02aa01 F. D. Z. 01.01.27-31.12.28, Plus V. Option 1X12m is 05 Nov 2029. Submit before this date to be considered.

This tender has been issued by DAK HEALTH in Germany.

The estimated tender value is EUR 1.00. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152582359. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.